Irbesartan :
CAS : 138402-11-6 ; C25H28N6O ; MW: 428.53 ; |
Irbesartan Bromo N2-Trityl Impurity :
Losartan N2-Trityl Bromo Impurity ; Candesartan N2-Trityl Bromo Impurity ; CAS : 124750-51-2 ; C33H25BrN4 ; MW: 557.48 ; |
Irbesartan Bromo Nitrile Impurity :
4-(Bromomethyl)biphenyl-2-carbonitrile ; CAS : 114772-54-2 ; C14H10BrN ; MW: 272.14 ; |
Irbesartan Cyano Impurity :
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile ; CAS : 138401-24-8 ; C25H27N3O ; MW: 385.5 ; |
Irbesartan Dibromomethyl Impurity :
4-(Dibromomethyl)biphenyl-2-carbonitrile ; C14H9Br2N ; MW: 351.04 ; |
Irbesartan Impurity A :
CAS : 748812-53-5 ; C25H30N6O2 ; MW: 446.54 ; |
Irbesartan Hydroxy Impurity :
Losartan Hydroxy Impurity ; Losartan EP Impurity B ; C33H26N4O ; MW: 494.59 ; |
Irbesartan Hydroxy N2-Trityl Impurity :
Candesartan Hydroxy N2-Trityl Impurity ; Losartan Hydroxy N2-Trityl Impurity ; Valsartan Hydroxy N2-Trityl Impurity ; C33H26N4O ; MW: 494.59 ; |
Irbesartan Lactam Impurity:
2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride ; CAS : 151257-01-1 ; C11H19ClN2O ; MW: 230.73 ; |
Irbesartan Methyl Impurity :
5-(4-Methyl-(1,1-biphenyl)-2-yl)-1H-tetrazole ; Candesartan Methyl Impurity ; Losartan EP Impurity E ; Losartan Methyl Impurity ; CAS : 120568-11-8 ; C14H12N4 ;MW: 236.27 ; |
Irbesartan N2-Trityl Impurity:
N2-Trityl Irbesartan ; CAS : 886999-35-5 ; C44H42N6O ; MW: 670.84 ; |
Irbesartan Propyl Analog:
2-Propyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one ; C24H26N6O ; MW: 414.50 ; |